Tilray Brands TLRY
NASDAQ TLRY
$4.68 -0.15 (-3.11%)
As of: Aug 20, 2026 · 3:59 PM EDT

Tilray Brands (TLRY) Cash from Financing Activities (2017 - 2026)

Tilray Brands' (TLRY) quarterly Cash from Financing Activities came in at $68.2 million in Q2 2026, up 309.65% YoY from $16.6 million in Q2 2025, and up 1429.45% on a QoQ basis from -$5.1 million in Q1 2026.

Tilray Brands (TLRY) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Tilray Brands (TLRY) has 10 years of Cash from Financing Activities data on file, last reported at $68.2 million in Q2 2026.

  • Quarterly Cash from Financing Activities rose 309.65% year-over-year to $68.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $131.0 million (down 1.88% YoY) and the FY2026 annual result came in at $131.0 million, down 1.88% from the prior year.
  • Cash from Financing Activities rose to $68.2 million in Q2 2026, from -$5.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $161.8 million in Q2 2022 to a low of -$85.4 million in Q4 2023.
  • A 5-year average of $23.1 million and a median of $15.3 million in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 1639.86% — and 2024, when it slumped 346.72%.
  • Tracing TLRY's Cash from Financing Activities over 5 years: stood at -$57.3 million in 2022, then tumbled by 49.1% to -$85.4 million in 2023, then surged by 144.75% to $38.2 million in 2024, then increased by 25.91% to $48.1 million in 2025, then soared by 41.73% to $68.2 million in 2026.
  • The last three Cash from Financing Activities figures came in at $68.2 million (Q2 2026), -$5.1 million (Q1 2026), and $48.1 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -1.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -813.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -1.13 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 122.40 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -1.24 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 63.40 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -74.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Tilray Brands 523.93 Mn 289.30 Mn 90.52 Mn 68.17 Mn

Historic Data

Download Data
DateValue
May 31, 2026 68.17 Mn
May 31, 2026 68.17 Mn
Feb 28, 2026 -5.13 Mn
Feb 28, 2026 -5.13 Mn
Nov 30, 2025 48.10 Mn
Nov 30, 2025 48.10 Mn
Aug 31, 2025 19.85 Mn
Aug 31, 2025 19.85 Mn
May 31, 2025 16.64 Mn
May 31, 2025 16.64 Mn
Feb 28, 2025 18.07 Mn
Feb 28, 2025 18.07 Mn
Nov 30, 2024 38.20 Mn
Nov 30, 2024 38.20 Mn
Aug 31, 2024 60.59 Mn
Aug 31, 2024 60.59 Mn
May 31, 2024 7.07 Mn
May 31, 2024 7.07 Mn
Feb 29, 2024 -10.91 Mn
Feb 29, 2024 -10.91 Mn